Description: Develops targeted molecular imaging agents and therapeutics to detect and treat cancer and cardiovascular disease earlier and more specifically than currently possible. The company aims to detect disease, meaning earlier diagnosis; target drug delivery, potentially signifying higher doses with fewer side effects; and monitoring treatment, effectively personalizing therapy.